PRGO
Perrigo Co. Plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IE
$13.66
+0.52%Price chart
Aug 12Aug 17Aug 20Aug 25Aug 28Sep 2Sep 8Sep 11
ValuationView details →
P/E (Fwd)
5.8x
EV/EBITDA
−3.9x
Market Cap
$1.90B
MomentumView details →
1D Return
+0.52%
YTD Return
−1.39%
RSI (14)
52.0
ValuationView details →
P/E (Fwd)
5.8x
EV/EBITDA
−3.9x
Market Cap
$1.90B
RSI (14)
52.0
MomentumView details →
1D Return
+0.52%
YTD Return
−1.39%
SummaryUpdated Jun 1, 2026
Perrigo Company plc (NYSE:PRGO) is a Dublin-based consumer healthcare company founded in 1887 that has evolved from a small Michigan pharmacy into a global leader in over-the-counter health and wellness products. The company operates as one of the world's largest manufacturers of store-brand consumer healthcare products, serving both retail chains and consumers directly through its own branded products. Perrigo has undergone significant transformation in recent years, divesting its prescription pharmaceuticals business to focus exclusively on consumer self-care products across the Americas and international markets.
Similar companies
Latest newsMore news →
Perrigo Company plc reported financial results from continuing operations for the second quarter ended June 27, 2026, highlighting market share growth in U.S. store-brand OTC and key European brands, completion of the Dermacosmetics divestiture, and reaffirmed full-year 2026 outlook.39d agoPerrigo Company plc announced a quarterly dividend of $0.29 per share, payable on September 15, 2026, to shareholders of record on August 28, 2026.44d agoPerrigo Company plc appointed Salman Amin and Omer Gajial as independent directors to its Board, effective June 30, 2026.74d ago